Krystal Biotech

Delivers gene therapies through engineered viruses that insert corrective DNA like retroviruses integrate into host genomes. Their HSV-1 based treatments target genetic skin diseases, reprogramming patient cells to produce missing proteins through viral vectors that have evolved to penetrate epithelial barriers.